Skip to content

Protective Barrier Film 740013Recalls & reported problems

C. R. Bard, Inc. · Protective Barrier Film · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10801741072779), received between Aug 29, 2017 and Oct 21, 2017 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Device Reprocessing Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Reprocessing Problem1
  • Failure To Adhere Or Bond1

Patient problems

  • Discharge1
  • Erythema1
  • No Known Impact Or Consequence To Patient1
  • Rash1
  • Skin Tears1
  • Unspecified Infection1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 21, 2017Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT AFTER USE OF THE DEVICE, THE PATIENT EXPERIENCED REDNESS, RAISED SKIN, SKIN TEAR, DRAINAGE, AND FOUL ODOR. THE AREA OF THE ALLEGEDLY INFECTED SKIN WAS THE SAME CIRCUMFERENCE AS THE LIBRE PRO CONTINUOUS GLUCOSE MONITOR. ALLEGEDLY, ALCOHOL WAS USED TO CLEAN THE PATIENT'S SKIN BEFORE PLACING THE PROTECTIVE BARRIER FILM ON THE SKIN. THEN, A LIBRE PRO CONTINUOUS GLUCOSE MONITOR WAS PLACED IN THE PATIENTS SKIN WITH A NEEDLE. THE PROTECTIVE BARRIER FILM WAS USED ON THE PATIENTS SKIN FOR 13 DAYS. ALLEGEDLY, THE PATIENT VISITED A NON-EMERGENT CARE FACILITY DUE TO THE EXPERIENCED REDNESS, RAISED SKIN, SKIN TEAR, DRAINAGE, AND FOUL ODOR. IT WAS LATER REPORTED, THE PATIENT WAS PRESCRIBED AN ANTIBIOTIC CALLED KEFLEX AND A TOPICAL ANTIBIOTIC. THE LOCATION OF THE ALLEGED INFECTED SKIN WAS ON THE PATIENT'S RIGHT ARM.

    Patient problems: Discharge; Erythema; Rash; Skin Tears; Unspecified Infection

    MAUDE report 6967582 ↗
  • MalfunctionAug 29, 2017Failure To Adhere Or Bond; Device Reprocessing Problem

    IT WAS REPORTED THAT THE WIPES DID NOT CLEAN THE PATIENT'S SKIN THOROUGHLY; AS A RESULT HIS DIABETIC EQUIPMENT DID NOT ADHERE PROPERLY.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6826520 ↗

Other Bandage, liquid, skin protectant devices

All Bandage, liquid, skin protectant devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page